Roger Auth is a Respiratory physician affiliated with Brown University. OpenAlex indexes 21 publications with 732 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
375 Wampanoag Trl
Riverside, RI 029152232
Telephone
401-649-4070Provider last certified this registry record 28 Apr 2026.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- INTUITIVE SURGICAL, INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
64.7%Corticosteroid43.7%Trelegy Ellipta84%Fluticasone Propionate16%Part D<11 patientsbeta2-Adrenergic Agonist21%Albuterol Sulfate Hfa100%Part D≥12 patientsMetabolism & gastrointestinal
26.9%Corticosteroid10.8%Prednisone100%Part D<11 patientsH2 blocker9%Famotidine100%Part D<11 patients+ 1 more class in this area
Anti-infectives
8.4%Macrolide Antimicrobial8.4%Azithromycin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Corrigendum to “Glucagon-like Peptide 1 Agonist Use in an Adult With Cystic Fibrosis–Related Diabetes and Metabolic Syndrome”
AACE Endocrinology and Diabetes
2026 - Glucagon-Like Peptide 1 Agonist Use in an Adult With Cystic Fibrosis–Related Diabetes and Metabolic Syndrome
AACE Endocrinology and Diabetes
2025 - Impact of Elexacaftor/Tezacaftor/Ivacaftor on Cardiopulmonary Exercise Testing in Adults with Cystic Fibrosis: A Retrospective Study
Annals of the American Thoracic Society
2025 - Improving Inpatient Cystic Fibrosis Exacerbation Care: A Resident Physician Training Approach.
PubMed
2025 - 734 No stone unturned: using cross-sectional imaging studies to assess cardiovascular risk in cystic fibrosis
Journal of Cystic Fibrosis
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Frank Sellke, MD
Brown University
Josiah Rich, MD
Brown University
Donald Coustan, MD
Brown University
Audrey Tyrka, MD, PhD
Brown University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”